News

TAVR valve for AR , a recent Edwards acquisition, delivers long-term value

The J-Valve System is associated with positive 10-year outcomes for patients with severe AR, according to new research out of China. It also performs well in patients with severe AS.

Cardiologist impressed by experimental pill that significantly lowers cholesterol

An experimental oral PCSK9 inhibitor is associated with LDL-C reductions that could prove to be a game-changer for patient care.

Cardiologists urge Congress to pass new bills focused on PAD, Medicare coverage

SCAI has shared a new call to action as an observance of American Heart Month. The group is asking Congress to pass new pieces of legislation that could improve care for PAD patients and get important medical devices in the hands of interventional cardiologists.

FDA announces recall of Johnson & Johnson devices after multiple injuries, 1 death

Several detachable coil systems are being recalled due to a higher-than-expected failure to detach rate. Customers should not use them going forward.

New recall includes nearly 23K bottles of triglycerides drug used to treat heart disease

New Jersey-based Zydus Pharmaceuticals has recalled nearly 23,000 bottles of its icosapent ethyl capsules due to leakage issues that may have weakened their effectiveness.

SAVR linked to ‘excellent’ long-term survival for patients with bicuspid aortic valves

Survival rates are high for both men and women presenting with BAV disease, according to a new analysis of nearly 28,000 SAVR patients.

New meta-analysis explores potential of endovascular treatments for long femoropopliteal lesions

Open surgical bypass is the gold standard, but endovascular therapies may provide value for high-risk patients with long femoropopliteal lesions.

Cardiologist sparks fresh debate over mandatory vaccines

The cardiologist at the head of an influential CDC panel sees serious problems with modern vaccine policies. While many experts seem to disagree, one organization has jumped to his defense.

Screening older patients for AFib during regular care is feasible, but not productive

Screening did provide some value for patients 85 years and older, but more research is still required.

Young patient recovering after world’s first combination heart transplant and thymus procedure

“This has the potential to change the face of solid organ transplantation in the future,” one surgeon said.

Tofacitinib increases risk of heart issues, cancer among rheumatoid arthritis patients

The FDA and Pfizer worked together to develop this new analysis of more than 4,000 patients.

DOACs an effective substitute for VKAs after AFib patients undergo bioprosthetic valve replacement

Direct oral anticoagulants are noninferior to vitamin K antagonists when treating this important patient population, researchers reported.

Around the web

Radiology Business

Overview of the new GE HealthCare photon-counting scanner technology

Tim Szczykutowicz, PhD, associate professor radiology, University of Wisconsin Madison, explains the new technology developments in GE HealthCare's FDA 510(k)-pending photon-counting CT scanner.